Frequent aspirin use linked to increased bleeding
A study has found that long term aspirin use increases patients' risk of major bleeding events by 43 percent, with 1 in 200 having a major bleed...
List view / Grid view
News
Cancer drug with accelerated approval fails Phase III trial
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
European approval for combination lumacaftor/ivacaftor paediatric cystic fibrosis drug
A paediatric treatment for 2 to 5 year olds has been approved by the European Commission to treat children with the most common form of cystic fibrosis...
Blood test for early detection of severe lung-transplant rejections
A blood test could identify whether a newly transplanted lung is being rejected by a patient, despite there being no outward features...
Combination therapy for coinfection with HIV and leishmaniasis
A combination of AmBisome monotherapy and miltefosine could be beneficial when treating a coinfection of HIV and visceral leishmaniasis...
Chemical structures quickly revealed using enhanced NMR
Researchers have developed an enhanced NMR method that could determine the structures of complex molecules much quicker than before...
FDA grant to help increase generic drugs delivered intravaginally or by IUD
Of the 21 drugs designed for delivery directly to the female genital tract, only four have a cost-effective, generic equivalent...
Computer programme that could bypass patents to produce synthetic drugs
Software that can bypass current intellectual property and design medication with the same function as top drugs could help pharma companies...
European Commission approves prostate cancer treatment Erleada
Erleada (apalutamide) has been approved for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
Arfolitixorin linked to tumour shrinkage in colorectal cancer
A Phase I/IIa study has shown that arfolitixorin along with either irinotecan or oxaliplatin could shrink the size of tumours in colorectal cancer patients...
Almac Group extends personalised cancer vaccine production facilities
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
Increases in patients combining drugs could be dangerous
Combining benzodiazepines, opioids and Z-drugs could prove to cause serious adverse outcomes including breathing problems and fatalities...
Experts push the boundaries of 3D microscopy
Researchers have developed a method that can use 3D microscopy to develop ALMOST, A Label-free Multicolor Optical Surface Tomography...
Generic version of seizure drug Sabril gets FDA approval
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
Losartan could improve ovarian cancer treatment
Researchers have found that losartan could be beneficial for those undergoing cancer treatment as it may enhance its effectiveness...
